Edition:
United States

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

1.36USD
1:11pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.36
Open
$1.38
Day's High
$1.38
Day's Low
$1.36
Volume
8,193
Avg. Vol
120,618
52-wk High
$2.65
52-wk Low
$0.69

Select another date:

Mon, Feb 12 2018

BRIEF-VistaGen Therapeutics Reports Qtrly Loss Per Share $‍0.25​

* VISTAGEN THERAPEUTICS REPORTS THIRD QUARTER FISCAL 2018 FINANCIAL RESULTS

BRIEF-Vistagen Therapeutics ‍Prepares To Initiate Its Phase 2 Study Of Av-101 For Major Depressive Disorder​

* VISTAGEN THERAPEUTICS INC - ‍PREPARES TO INITIATE ITS PHASE 2 STUDY OF AV-101 FOR MAJOR DEPRESSIVE DISORDER​ Source text for Eikon: Further company coverage:

Select another date: